Thyroid Storm with Heart Failure Treated with a Short-acting Beta-adrenoreceptor Blocker, Landiolol Hydrochloride.
暂无分享,去创建一个
M. Iguchi | M. Abe | M. Akao | Y. Yamashita | Y. Hamatani | H. Ogawa | M. Ishii | T. Usui | D. Takagi | N. Masunaga | Rieko Nakatani | T. Unoki
[1] M. Yano,et al. A Low-Dose β1-Blocker Effectively and Safely Slows the Heart Rate in Patients with Acute Decompensated Heart Failure and Rapid Atrial Fibrillation , 2013, Cardiology.
[2] T. Maruyama,et al. [Anesthetic and perioperative management of a patient with uncontrolled thyrotoxicosis undergoing coronary artery bypass grafting surgery]. , 2013, Masui. The Japanese journal of anesthesiology.
[3] M. Wang,et al. Pharmacokinetics, Pharmacodynamics, and Safety of Landiolol Hydrochloride in Healthy Chinese Subjects , 2013, Drug Research.
[4] W. Shimizu,et al. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study). , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[5] Y. Iwao,et al. [Case of thyroid crisis with persistent tachycardia diagnosed postoperatively]. , 2009, Masui. The Japanese journal of anesthesiology.
[6] Yasuki Fujita,et al. [Perioperative and postoperative management of two patients with uncontrolled hyperthyroidism using short acting beta blocker, landiolol]. , 2008, Masui. The Japanese journal of anesthesiology.
[7] R. Dalan,et al. Cardiovascular collapse associated with beta blockade in thyroid storm. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[8] C. Lau,et al. Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism , 2006, Heart.
[9] A. Iagaru,et al. Treatment of thyrotoxicosis. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] J. Kosaka,et al. [Successful anesthetic management of a patient with thyroid storm using landiolol]. , 2007, Masui. The Japanese journal of anesthesiology.
[11] K. Burman,et al. Thyrotoxicosis and thyroid storm. , 2006, Endocrinology and metabolism clinics of North America.
[12] B Gerbert,et al. [Thyroid hormone and the cardiovascular system]. , 2005, Deutsche medizinische Wochenschrift.
[13] V. Ojetti,et al. Management of thyrotoxic crisis. , 2005, European review for medical and pharmacological sciences.
[14] N. Sarlis,et al. Thyroid Emergencies , 2004, Reviews in Endocrine and Metabolic Disorders.
[15] F. Boccalandro,et al. Severe reversible dilated cardiomyopathy and hyperthyroidism: case report and review of the literature. , 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[16] R. Choudhury,et al. Heart failure in thyrotoxicosis, an approach to management. , 1998, British journal of clinical pharmacology.
[17] G. Umpierrez,et al. Congestive Heart Failure Due to Reversible Cardiomyopathy in Patients With Hyperthyroidism , 1995, The American journal of the medical sciences.
[18] M. Leinung,et al. Thyroid storm. , 1995, The Medical clinics of North America.
[19] L. Wartofsky,et al. Life-threatening thyrotoxicosis. Thyroid storm. , 1993, Endocrinology and metabolism clinics of North America.
[20] A. Burger,et al. 5 Thyroid emergencies , 1992 .
[21] L. Gavin. Thyroid crises. , 1991, The Medical clinics of North America.
[22] A. Toft,et al. Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. , 1982, The New England journal of medicine.
[23] G. Hughes. Management of Thyrotoxic Crises with a Beta‐Adrenergic Blocking Agent (Pronethalol) , 1966, The British journal of clinical practice.
[24] R. Mustard. Treatment of thyrotoxicosis. , 1956, Canadian Medical Association journal.
[25] D. M. Rossiískií. [Treatment of thyrotoxicosis]. , 1955, Problemy endokrinologii i gormonoterapii.
[26] D. Tan,et al. THYROTOXIC heart disease. , 2006, The Heart bulletin.